SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CD&R Associates VIII, Ltd.

(Last) (First) (Middle)
C/O CLAYTON, DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NCI BUILDING SYSTEMS INC [ NCS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.01 par value 05/14/2013 C(2) 54,136,817 A(2) $0(2) 54,136,817 I See note(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Cumulative Conv. Participating Preferred Stock $6.374(1) 05/14/2013 C(2) 339,293.4704(2)(3) (3) (3) Common Stock, $0.01 par value 54,136,817 (1) 0 I See note(4)
1. Name and Address of Reporting Person*
CD&R Associates VIII, Ltd.

(Last) (First) (Middle)
C/O CLAYTON, DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
CLAYTON DUBILIER & RICE FUND VIII LP

(Last) (First) (Middle)
C/O CLAYTON & DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
CD&R FRIENDS & FAMILY FUND VIII LP

(Last) (First) (Middle)
C/O CLAYTON, DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
CD&R ASSOCIATES VIII, LP

(Last) (First) (Middle)
C/O CLAYTON, DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
CD&R Investment Associates VIII, Ltd.

(Last) (First) (Middle)
C/O CLAYTON, DUBILIER & RICE, INC.
375 PARK AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10152

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This conversion price ("Conversion Price") was calculated based on an initial conversion price of $1.2748 adjusted to give effect to the 1 for 5 reverse stock split of the common stock, par value $0.01 (the "Common Stock") of the issuer that became effective on March 5, 2010 (the "Reverse Stock Split").
2. On May 14, 2013 Clayton, Dubilier & Rice Fund VIII, LP ("Fund VIII") and CD&R Friends & Family Fund VIII, LP ("F&F VIII") delivered a Notice of Conversion to the issuer exercising the right to convert (i) in the aggregate, 339,293.4704 shares of Series B Cumulative Convertible Participating Preferred Stock (the "Series B Stock") into shares of Common Stock and (ii) undeclared and unpaid dividends of $5,774,610.52 accrued in 2009 with respect to the Series B Stock into shares of Common Stock. In connection with such conversion (the "Conversion"), the issuer issued, for no additional consideration pursuant to the terms of the Amended and Restated Certificate of Designations relating to the Series B Stock, 54,001,628 shares of Common Stock to Fund VIII and 135,189 shares of Common Stock to F&F VIII.
3. The terms and conditions of the Series B Stock were previously disclosed in the Form 3 and Forms 4 relating to Fund VIII's and F&F VIII's acquisition and ownership of Series B Stock.
4. Prior to the Conversion, Fund VIII directly owned 338,439.8334 shares of the Series B Stock and F&F VIII directly owned 853.6370 shares of the Series B Stock. As general partner of both Fund VIII and F&F VIII, CD&R Associates VIII, Ltd. may have been deemed to own directly a total of 339,293.4704 shares of Series B Stock. CD&R Associates VIII, L.P., CD&R Associates VIII, Ltd. and CD&R Investment Associates VIII, Ltd. expressly disclaimed beneficial ownership of the shares of Series B Stock previously held by Fund VIII and F&F VIII. CD&R Associates VIII, Ltd. is a wholly-owned subsidiary of CD&R Associates VIII, L.P., of which CD&R Investment Associates VIII, Ltd. is the general partner.
5. Following the Conversion, Fund VIII directly owns 54,001,628 shares of Common Stock and and F&F VIII directly owns 135,189 shares of Common Stock. As general partner of both Fund VIII and F&F VIII, CD&R Associates VIII, Ltd. may be deemed to own directly a total of 54,137,817 shares of Common Stock. CD&R Associates VIII, L.P., CD&R Associates VIII, Ltd. and CD&R Investment Associates VIII, Ltd. expressly disclaim beneficial ownership of the shares of Common Stock held by Fund VIII and F&F VIII. CD&R Associates VIII, Ltd. is a wholly-owned subsidiary of CD&R Associates VIII, L.P., of which CD&R Investment Associates VIII, Ltd. is the general partner.
CD&R Associates VIII, Ltd. By: Theresa A. Gore, VP, Treas. and Asst. Sec. 05/16/2013
Clayton, Dubilier & Rice Fund VIII, L.P. By: CD&R Associates VIII, Ltd., its general partner By: Theresa A. Gore, VP, Treas. and Asst. Sec. 05/16/2013
CD&R Friends & Family Fund VIII, L.P. By: CD&R Associates VIII, Ltd., its general partner By: Theresa A. Gore, VP, Treas. and Asst. Sec. 05/16/2013
CD&R Associates VIII, L.P. By: CD&R Investment Associates VIII, Ltd., its general partner By: Theresa A. Gore, VP, Treas. and Asst. Sec. 05/16/2013
CD&R Investment Associates VIII, Ltd. By: Theresa A. Gore, VP, Treas. and Asst. Sec. 05/16/2013
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.